Searchable abstracts of presentations at key conferences in endocrinology

ea0021p221 | Endocrine tumours and neoplasia | SFEBES2009

Pro-opiomelanocortin is a novel biomarker for small cell lung cancer

Stovold Rachel , Stevens Adam , Ray David , Sommers Paula , Dive Caroline , Blackhall Fiona , White Anne

Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumour that shows early metastasis and resistance to chemotherapy. Current biomarkers focus on prognosis and diagnosis but there is a need to find novel biomarkers, which could, for example, identify patients at risk of cerebral metastases.Pro-opiomelanocortin (POMC), the precursor of ACTH is a well-recognised biomarker of the ectopic ACTH syndrome1, of which SCLC is the most preval...

ea0090ep732 | Pituitary and Neuroendocrinology | ECE2023

Pituitary metastasis in neuroendocrine neoplasms, lesson learned from cases reports

Ganawa Shawg , Ilyas Waqas , Irshad Shadman , Hamad Adeel , Pathmanaban Omar , Milanovic Dusan , Colaco Rovel , Blackhall Fiona , Valle Juan , Ho Jan Hoong , Adam Safwaan

Introduction: Pituitary metastases (PM) are an uncommon manifestation of Neuroendocrine neoplasms (NENs) and are rarely reported. We report two cases of PM with different clinical lessons.Case 1: A 37-year-old female underwent surgical resection for a high grade poorly differentiated neuroendocrine carcinoma of the cervix (Ki67 90%). Serial follow-up surveillance assessments revealed disease progression (local, liver, lung, and bone) for which she underw...